Manuel B. Garcia

Manuel B. Garcia serves as the Senior Director for Educational Technology and Digital Learning at FEU Institute of Technology, Manila, Philippines. Read More

Contact Info

1607, FEU Tech Building,
P. Paredes St, Sampaloc,
Manila, Philippines
mbgarcia@feutech.edu.ph

Follow Me

How Do You Use Companion Papers Without Double-Counting Participants?

Companion papers can contain valuable outcomes, methods, harms, and follow-up data that the main publication omits. The key is to use those reports as sources for one study without treating their shared participants as independent evidence.

278
Using Companion Papers Without Double-Counting Guide 278 of 899
01 · The Question

How Can You Keep Useful Companion Papers Without Counting the Same People Twice?

You identify a primary study report and then discover several related papers. One provides adverse-event data, another reports a secondary outcome, and a third contains long-term follow-up results. They all contain information your review could use.

Discarding the companion papers would lose potentially important evidence. Treating every paper as a separate independent study creates the opposite problem: the same participants may be represented repeatedly.

The solution is to separate two tasks that are easy to conflate. Use publications as sources of information, but organize that information around the underlying study and participant population. Cochrane explicitly recommends collating multiple reports of the same study rather than treating each report as another study.

02 · The Short Answer

Link the Reports First, Then Extract at the Study Level

In Brief

Use companion papers by linking them to one study record, extracting whatever unique information each contributes, and making sure that effect estimates based on the same or overlapping participants are not entered into a synthesis as though they came from independent samples.

A companion paper does not need to be discarded simply because its participants appear elsewhere. It may supply a different outcome, time point, subgroup, methodological detail, or correction. The important question is what information it contributes and whether the participants behind a particular estimate have already contributed to the same synthesis.

03 · What You Need to Know

How to Separate Useful Information From Duplicate Participant Contributions

Start With the Study, Not the Paper

Systematic reviews commonly retrieve reports rather than neatly packaged studies. One study may be represented by a journal article, conference abstract, protocol, registry entry, secondary analysis, follow-up report, and other sources. Cochrane therefore treats the study, rather than each individual report, as the principal unit of interest.

Once you have established that several publications arise from the same investigation, assign them to a common study identifier. Each publication should retain its own report identifier so that you can trace exactly where information came from.

Study ID Identifies the underlying investigation and connects all of its reports.
Report ID Identifies the particular publication or source from which a piece of information was obtained.

This simple distinction prevents a common data-management problem: allowing the structure of your bibliography to dictate the structure of your evidence.

Companion Papers May Contain Information the Main Paper Does Not

A secondary report should not be discarded without examination. Cochrane notes that a single source rarely contains complete information about a study and specifically cautions that secondary reports may contain valuable information about study design, conduct, outcomes, and results.

A companion paper might provide:

  • an outcome omitted or abbreviated in the main report;
  • adverse events or harms;
  • longer-term follow-up;
  • details of intervention implementation;
  • a subgroup or secondary analysis;
  • additional information about methods or participant flow;
  • results for another measurement instrument; or
  • information that helps explain an apparent discrepancy elsewhere.

Using this information does not mean counting another study. You are enriching the record of the same underlying investigation.

Ask Whether the Same Participants Enter the Same Synthesis More Than Once

Double-counting becomes particularly consequential when two estimates based on the same participants are entered into one analysis as though they were independent.

Suppose a randomized trial of 500 participants produces two papers. Paper A reports depression using Scale X, while Paper B reports depression using Scale Y in the same participants at the same follow-up. If both effect estimates are entered into a conventional meta-analysis as if they came from two independent studies, the underlying trial may receive unintended extra influence.

By contrast, if Paper A reports depression and Paper B reports an eligible adverse-event outcome, both reports may contribute useful information to different outcome syntheses without duplicating participants within either synthesis.

Situation Can Both Reports Be Useful? Double-Counting Concern
Same participants, different eligible outcomes Yes Usually manageable when outcomes are synthesized separately
Same participants, same outcome, different instruments Yes, but a selection or synthesis rule is needed Potentially substantial if both are treated as independent estimates
Same participants, different follow-up times Yes Depends on whether time points enter separate or combined syntheses
One report analyzes a subgroup of the main sample Potentially Important if subgroup and full-sample estimates enter the same synthesis
Companion paper supplies only methodological information Yes No participant double-counting from using descriptive information alone

Do Not Confuse Data Extraction With Meta-Analytic Inclusion

You can extract information from a report without placing every number it contains into a meta-analysis. These are separate decisions.

For example, a subgroup paper may clarify treatment adherence or provide a relevant descriptive characteristic. You can use that information in the study record even if its subgroup effect estimate is not eligible for the primary quantitative synthesis.

This distinction is useful because an overly aggressive response to duplication can lead reviewers to discard informative reports merely to keep the dataset tidy. Methodological neatness is desirable, of course, but preferably not at the expense of actual information.

Map Which Participants Contribute to Which Result

When companion reports are complex, create a small outcome-by-report map. Record the participants, outcome, measurement instrument, time point, and analytic population behind each potentially eligible result.

Report Which publication contains the result?
Population Full randomized sample, complete cases, subgroup, or follow-up participants?
Outcome What construct or endpoint is being reported?
Time point When was the outcome measured?
Synthesis destination Which review outcome or analysis, if any, could this estimate enter?

This makes it easier to see whether two apparently different results are actually alternative measurements of the same outcome in the same people.

Prespecify Rules for Multiple Eligible Results

A study can report several eligible results for one outcome because of different instruments, subgroups, time points, or statistical summaries. Cochrane recommends specifying in the protocol how such multiplicity will be handled, rather than choosing among results after seeing which estimate is most favorable or convenient.

Depending on the review question, a protocol might specify preferred measurement instruments, clinically meaningful time windows, preferred analysis populations, or another defensible hierarchy. More complex synthesis methods may sometimes accommodate correlated estimates rather than requiring selection of only one, but the method must actually account for the dependence.

Different Follow-Up Times Require an Outcome-Time Framework

Companion papers frequently report later follow-up. Suppose the primary report provides a three-month outcome and another paper reports the same participants at 12 months. Both results may be relevant if your protocol defines short-term and long-term outcome windows.

They should not, however, silently become two independent studies. They are repeated observations from the same underlying investigation.

Subgroup Papers Require Participant-Level Awareness

A companion analysis might use only women, participants above a particular age, one study site, or participants with a particular baseline condition. If those people are already represented in a full-sample estimate, adding the subgroup estimate to the same analysis can count them again.

This is why you need to know whether two papers use the same participants and whether the samples constitute an overlapping study population.

Do Not Assume the Primary Report Is Correct Whenever Reports Disagree

Companion papers can expose inconsistencies. Sample sizes, event counts, outcome definitions, or effect estimates may differ across reports. Cochrane recommends planning how discrepancies across sources will be resolved and, where necessary, contacting investigators.

Sometimes the discrepancy is legitimate: the papers use different follow-up periods or analysis populations. Sometimes a later publication corrects an earlier value. Occasionally the available sources do not permit reconciliation. The appropriate response is investigation and documentation, not automatic deference to whichever publication you labeled primary.

Watch Out

“Use one paper per study” is not a safe rule. It can prevent duplicate estimates, but it can also throw away unique outcomes, follow-up information, harms, and methodological details. The better rule is to use all relevant reports while controlling which participant contributions enter each synthesis.

04 · A Practical Example

Using Four Papers From One Trial Without Turning Them Into Four Trials

Hypothetical Example

One Trial, Four Companion Reports

Imagine a randomized trial involving 600 university students. Four papers are relevant to your review.

Paper A Reports the primary mental-health outcome at three months for 570 participants.
Paper B Reports adverse events for the full randomized population.
Paper C Reports the same mental-health construct at three months using another instrument in 552 of the same participants.
Paper D Reports the mental-health outcome at 12 months for 480 participants who remained in follow-up.

All four papers can be useful. Paper A can supply the prespecified short-term mental-health result. Paper B can supply harms. Paper D can supply the long-term outcome if your review includes that time window.

Paper C requires more care. If its result measures the same outcome and time point as Paper A in substantially the same participants, simply entering both as independent studies would duplicate the trial's contribution. Your prespecified outcome-selection rule should determine which measure is used, or your analytical method must explicitly accommodate the dependence.

Your study table still contains one underlying trial. Its linked reports explain where each piece of information originated.

05 · What Researchers Often Get Wrong

Common Mistakes When Working With Companion Publications

Misconception

Only the Primary Report Should Be Used

A companion paper may contain the only available information about an eligible outcome, harms, follow-up period, or study procedure. Cochrane explicitly advises against discarding secondary reports without careful examination.

Misconception

Every Companion Paper Creates Double-Counting

Merely consulting or extracting information from several reports does not double-count participants. The problem arises when overlapping participant contributions are treated as independent within a synthesis or when several reports are mistakenly counted as several studies.

Misconception

Different Outcomes Mean Independent Evidence

Different outcomes may come from exactly the same people. The outcomes can legitimately inform different review questions, but the publications do not thereby become independent replications of the study.

Misconception

A Smaller Companion Sample Must Be a Different Population

It may simply contain complete cases, a subgroup, or participants retained at follow-up. If a follow-up paper uses only part of the original sample, the smaller number does not make those participants newly independent.

Misconception

You Can Choose Whichever Effect Estimate Looks Most Convincing

Selecting among multiple eligible results after seeing their magnitude or statistical significance can introduce selective decision-making. Eligibility and selection rules should be specified as clearly as possible before results are chosen for synthesis.

06 · What This Means for You

Track Reports Separately but Synthesize Participants Deliberately

A practical workflow is to maintain one study record with multiple linked report records. For every extracted result, preserve its source report, participant population, outcome, time point, and analysis type. Cochrane specifically recommends recording both study and report identifiers in data-collection systems when studies have multiple reports.

A simple decision framework

If a companion paper contains unique descriptive or methodological information
Use it to enrich the study record; this does not by itself double-count participants.
If it reports a different eligible outcome
Use the result in the appropriate outcome synthesis while retaining its connection to the same study.
If it reports the same outcome and time point in the same participants
Apply your prespecified selection rule or a method that appropriately handles dependent estimates.
If it reports a subgroup already contained in the full sample
Do not treat subgroup and full-sample estimates as independent contributions to the same synthesis.
If participant overlap cannot be determined
Record the uncertainty and investigate before assuming independence.

The aim is not to minimize the number of papers you use. It is to preserve the maximum relevant information while maintaining an accurate account of how many studies and participants actually generated it.

07 · A Quick Checklist

Before Using Data From a Companion Paper

For each companion report, check:
That the report has been linked to the correct underlying study.
Which participants or analytic population generated the reported result.
Whether those participants are already represented in another estimate being considered for the same synthesis.
Which outcome, measurement instrument, and follow-up time the report provides.
Whether the report contributes unique methods, harms, follow-up, or other information even if its effect estimate is not used.
Whether multiple eligible results require a prespecified selection rule or an analytical method that handles dependence.
Whether differences between reports have been reconciled or explicitly documented.
Whether both the study ID and source report remain traceable in your extraction records.
08 · Frequently Asked Questions

Questions About Companion Papers and Double-Counting

Can I extract data from more than one paper from the same study?

Yes. Cochrane explicitly recognizes that information often needs to be collated across multiple reports because one source may not contain everything required by the review.

Does citing two papers from the same study double-count participants?

No. Citation itself does not create double-counting. The concern arises when estimates based on the same or overlapping participants are treated as independent evidence in a synthesis or when the publications are incorrectly counted as separate studies.

Can two companion papers contribute to different meta-analyses?

Yes. If one provides an eligible outcome and another provides a different eligible outcome or follow-up period, each may supply data to the relevant synthesis. Their common study origin should still remain explicit.

What if two companion papers measure the same outcome differently?

Apply the outcome-selection rules established in your protocol, such as a preferred instrument or measurement hierarchy, or use an analytical approach that properly handles multiple dependent estimates. Do not simply count both as independent studies.

Should I keep a companion paper if I extract no numerical result from it?

Potentially, yes. It may still contribute methodological details, information about study conduct, participant flow, harms, corrections, or context needed to interpret the study.

What if I cannot tell whether the companion paper uses the same participants?

Compare study identifiers, sites, dates, sample characteristics, interventions, and related reports. If uncertainty remains and materially affects the synthesis, correspondence with study investigators may be needed. Cochrane recommends using multiple study characteristics rather than relying on a single clue.

09 · The Bottom Line

Use All Relevant Reports, but Count Participant Contributions Carefully

The Bottom Line

Companion papers can be valuable sources of outcomes, methods, harms, and follow-up information, but they should remain linked to their underlying study so that the same or overlapping participants are not treated as independent contributions to the same synthesis.

Keep study and report identities separate, map the population behind each result, and apply prespecified rules when several eligible estimates arise from the same participants. This preserves useful information without allowing publication volume to inflate the apparent amount of independent evidence.

10 · Sources and Further Reading

Authoritative Guidance on Multiple Study Reports

11 · Cite this Guide

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.

Has the Field Guide helped your research?

If a guide helped clarify a question, inform a research decision, or move your work forward, I would love to hear about your experience. Your story may also help other researchers discover the Field Guide.

Share Your Experience
Takes only a few minutes